Scarica l'app Stockscreener
3.07
5.86%
0.17
Dopo l'orario di chiusura:
3.02
-0.05
-1.63%
Macrogenics Inc Borsa (MGNX) Ultime notizie
Medtronic Outperforms MacroGenics in Financial Comparison - National Today
MGNX Earnings History & Surprises | EPS & Revenue Results | MACROGENICS INC (NASDAQ:MGNX) - ChartMill
MacroGenics, Inc. (NASDAQ:MGNX) Given Consensus Rating of "Hold" by Brokerages - marketbeat.com
Retail Trends: Can MacroGenics Inc disrupt its industryPortfolio Value Report & Smart Money Movement Alerts - baoquankhu1.vn
Investment Report: Can MacroGenics Inc expand its profit margins2026 Selloffs & Weekly Chart Analysis and Guides - baoquankhu1.vn
Vanguard reports 0 shares in MacroGenics (NASDAQ: MGNX) - Stock Titan
Aug Drivers: How does MacroGenics Inc compare to its peersMarket Activity Recap & Short-Term Swing Trade Alerts - baoquankhu1.vn
Treasury Yields: Can MacroGenics Inc disrupt its industry2026 AllTime Highs & Verified High Yield Trade Plans - baoquankhu1.vn
Patterns Watch: What is the next catalyst for MacroGenics IncCEO Change & Fast Exit Strategy with Risk Control - baoquankhu1.vn
VIX Spike: Can MacroGenics Inc be the next market leaderTrade Entry Summary & AI Driven Stock Price Forecasts - baoquankhu1.vn
MacroGenics (NASDAQ:MGNX) Share Price Crosses Above Fifty Day Moving AverageTime to Sell? - MarketBeat
Why is MacroGenics stock sinking Tuesday? - MSN
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Beha - GuruFocus
Sentiment Review: Will MacroGenics Inc outperform the market in YEAR2026 Big Picture & Fast Gain Stock Tips - baoquankhu1.vn
Bull Run: Is MacroGenics Inc attractive for institutional investorsWeekly Stock Analysis & Verified Momentum Watchlists - baoquankhu1.vn
MacroGenics Inc earnings missed by $0.03, revenue topped estimates - Investing.com Nigeria
MacroGenics (NASDAQ:MGNX) Upgraded to "Hold" at Wall Street Zen - MarketBeat
Who's Buying or Selling Macrogenics Inc (HAM:M55) Stock Today? - GuruFocus
Macrogenics Inc (HAM:M55) DCF Valuation - GuruFocus
MacroGenics at Barclays Conference: Strategic Therapeutic Focus By Investing.com - Investing.com Canada
MGNX: Multiple clinical milestones and strategic updates expected in 2026, backed by strong partnerships - TradingView
MacroGenics (NASDAQ:MGNX) Price Target Raised to $4.00 at Barclays - Defense World
MacroGenics (MGNX) Loss Of US$74.6 Million Tests Bullish Loss‑Narrowing Narrative - simplywall.st
Stifel reiterates MacroGenics stock rating with $4 price target By Investing.com - Investing.com Canada
Stifel reiterates MacroGenics stock rating with $4 price target - Investing.com India
MacroGenics at Leerink Global Healthcare Conference: Strategic Pipeline Focus By Investing.com - Investing.com Canada
Analysts Offer Insights on Healthcare Companies: MacroGenics (MGNX) and Cartesian Therapeutics (RNAC) - The Globe and Mail
MGNX Closes Up 45% On Wall Street Optimism For Experimental Cancer Therapies - Asianet Newsable
MGNX: Focused execution and pipeline progress set up major clinical milestones for mid-2026 - TradingView
Barclays Forecasts Strong Price Appreciation for MacroGenics (NASDAQ:MGNX) Stock - MarketBeat
MacroGenics (NASDAQ:MGNX) Announces Quarterly Earnings Results, Beats Estimates By $0.20 EPS - MarketBeat
Barclays Raises Price Target for Macrogenics (MGNX) to $4.00, Ma - GuruFocus
MacroGenics, Inc. 2025 Annual Report: Innovative Antibody-Based Cancer Therapeutics, Pipeline, and Risk Factors Overview - Minichart
MacroGenics Q4 2025 Earnings: Loss Below Estimates, Revenue Beats ForecastNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
MacroGenics (MGNX) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures - Bitget
MacroGenics: Fourth Quarter Earnings Overview - Bitget
MacroGenics: Q4 Earnings Snapshot - marketscreener.com
MacroGenics : Corporate Overview March 2026 - marketscreener.com
MacroGenics (NASDAQ: MGNX) details 2025 results, cash runway and key 2026 data - Stock Titan
MacroGenics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Chipmakers Recap: Can MacroGenics Inc expand its profit margins2026 Macro Moves & Low Risk Growth Stock Ideas - baoquankhu1.vn
Aug Breakouts: Can MacroGenics Inc disrupt its industryPortfolio Value Report & Long-Term Safe Investment Ideas - baoquankhu1.vn
MacroGenics Q1 2025 Earnings Preview - MSN
Risk Off: Will MacroGenics Inc. stock deliver consistent dividends2025 Growth vs Value & Detailed Earnings Play Strategies - Naître et grandir
Aug Retail: Will MacroGenics Inc outperform the market in YEARJuly 2025 Macro Moves & Long-Term Growth Plans - baoquankhu1.vn
Trade Recap: Can MacroGenics Inc expand its profit marginsWeekly Volume Report & Long-Term Growth Stock Strategies - baoquankhu1.vn
MacroGenics, Inc. (NASDAQ:MGNX) Given Average Rating of "Hold" by Analysts - MarketBeat
MGNX SEC FilingsMacrogenics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
MGNX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):